90%Confidence
0Views
FDASource
2026-04-20Date
Summary
Another 500 mL saline product recall underscores the severity and scale of Fresenius Kabi's manufacturing deficiencies. The company may face increased regulatory inspections and potential production halts.
Actionable: Await Fresenius Kabi's official response and remediation plan before making any investment decisions.
AI Confidence: 90%
Data Points
firmFresenius Kabi USA, LLC
classificationClass II
statusOngoing
distributionUS Nationwide , Alaska, and Puerto Rico.
product0.9% Sodium Chloride Injection, USP, (4,500 mg per 500 mL) (9 mg per mL) 500 mL in a 500 mL freeflex bag, Rx only, Fresenius Kabi USA, LLC ("Fresenius
Get Signals Instantly
Premium subscribers receive every signal via Telegram the moment it fires — hours before it appears here.
Subscribe Now